Atea Pharmaceuticals Inc (AVIR)
3.40
+0.02
(+0.74%)
USD |
NASDAQ |
Jun 27, 10:34
Atea Pharmaceuticals Price: 3.40 for June 27, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 26, 2024 | 3.41 | 3.49 | 3.34 | 3.375 | 222045.0 |
Jun 25, 2024 | 3.46 | 3.59 | 3.41 | 3.43 | 210571.0 |
Jun 24, 2024 | 3.44 | 3.555 | 3.41 | 3.49 | 200414.0 |
Jun 21, 2024 | 3.43 | 3.61 | 3.36 | 3.44 | 641153.0 |
Jun 20, 2024 | 3.46 | 3.58 | 3.40 | 3.42 | 231889.0 |
Jun 18, 2024 | 3.52 | 3.65 | 3.49 | 3.49 | 227132.0 |
Jun 17, 2024 | 3.60 | 3.65 | 3.515 | 3.53 | 387103.0 |
Jun 14, 2024 | 3.70 | 3.74 | 3.58 | 3.61 | 264277.0 |
Jun 13, 2024 | 3.78 | 3.85 | 3.69 | 3.70 | 233693.0 |
Jun 12, 2024 | 3.92 | 3.97 | 3.78 | 3.78 | 283351.0 |
Jun 11, 2024 | 3.76 | 3.92 | 3.69 | 3.92 | 223058.0 |
Jun 10, 2024 | 3.68 | 3.94 | 3.645 | 3.79 | 754470.0 |
Jun 07, 2024 | 3.75 | 3.85 | 3.695 | 3.70 | 162231.0 |
Jun 06, 2024 | 3.93 | 3.95 | 3.799 | 3.80 | 221140.0 |
Jun 05, 2024 | 3.80 | 4.005 | 3.80 | 3.96 | 302650.0 |
Jun 04, 2024 | 3.87 | 3.87 | 3.75 | 3.77 | 129359.0 |
Jun 03, 2024 | 3.67 | 3.89 | 3.643 | 3.89 | 266483.0 |
May 31, 2024 | 3.62 | 3.705 | 3.62 | 3.67 | 141116.0 |
May 30, 2024 | 3.56 | 3.67 | 3.56 | 3.61 | 167322.0 |
May 29, 2024 | 3.57 | 3.71 | 3.52 | 3.53 | 330501.0 |
May 28, 2024 | 3.68 | 3.70 | 3.58 | 3.61 | 249849.0 |
May 24, 2024 | 3.71 | 3.725 | 3.64 | 3.66 | 148489.0 |
May 23, 2024 | 3.81 | 3.81 | 3.68 | 3.69 | 164232.0 |
May 22, 2024 | 3.61 | 3.86 | 3.60 | 3.82 | 493535.0 |
May 21, 2024 | 3.60 | 3.70 | 3.585 | 3.61 | 167612.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.80
Minimum
Nov 22 2023
88.44
Maximum
Feb 08 2021
14.35
Average
6.05
Median
Mar 10 2022
Price Benchmarks
Cytokinetics Inc | 52.74 |
Insmed Inc | 69.25 |
PetMed Express Inc | 4.10 |
Sana Biotechnology Inc | 5.255 |
Prime Medicine Inc | 5.20 |
Price Related Metrics
PS Ratio | 0.8083 |
Price to Book Value | 0.5678 |
Earnings Yield | -57.65% |
Market Cap | 286.36M |
Operating PE Ratio | 2.053 |
Normalized PE Ratio | 2.500 |